| 标题 |
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Respiratory Medicine 作者:Bruno François; Simon Lambden; Tom Fivez; Sébastien Gibot; Marc Derive; et al 出版日期:2023-05-31 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)